Exact(17)
Today, I.B.M. stock fell $5.15, to $103, on a sharply lower day on Wall Street.
On a sharply lower day in the market, bank stocks were particularly weak, reflecting investor concerns that bank profits would be hurt if a strong economy prompted the Federal Reserve to again increase interest rates.
(Center, lower) Day 175, evident hyperreflective signals are pointed by arrowheads.
Catheter related infections were associated with better ICU survival and CR was associated with lower day 28 mortality.
Children with secondary acquired infection had lower day 3 5 mHLA-DR and higher pro-inflammatory cytokine concentrations (IL-6, IL-8 and TNF-α) at day 1 2 compared to children without secondary acquired infection.
On the other hand, ICU survivors had significantly lower day 1 IAP (13 ± 4 mmHg vs. 16 ± 5 mmHg, p = 0.015) and higher APP (59 ± 7 mmHg vs. 54 ± 8 mmHg, p = 0.02) compared to nonsurvivors.
Similar(42)
Google and Caterpillar threw markets lower Friday a day after the Dow closed above 14,000 for the first time.
Stocks edged slightly lower Thursday a day after the Dow Jones industrials closed at a record high.
The lower rate of hypoglycaemia, particularly nocturnal hypoglycaemia, observed with IDeg across trials is likely a consequence of its ultra-long and stable pharmacokinetic profile, and lower day-to-day variability in glucose-lowering action 23, 24.
The mean proportion was the same overall for both treatment groups in T2DM, suggesting that while similar proportions of patients in both treatment arms experienced hypoglycaemia, IDeg patients tended to experience fewer events, which is likely a result of the ultra-long and stable pharmacokinetic profile and the lower day-to-day variability in glucose-lowering action of IDeg [ 16– 16].
Treatment with IDeg might thus be expected to result in lower day-to-day variability in the glucose-lowering effect of basal-bolus therapy.
Write better and faster with AI suggestions while staying true to your unique style.
Since I tried Ludwig back in 2017, I have been constantly using it in both editing and translation. Ever since, I suggest it to my translators at ProSciEditing.

Justyna Jupowicz-Kozak
CEO of Professional Science Editing for Scientists @ prosciediting.com